Preliminary safety results of dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2 overexpressed/amplified breast cancer (BCA) Meeting Abstract


Authors: Dang, C. T.; Lin, N. U.; Lake, D.; Dickler, M. N.; Modi, S.; Seidman, A. D.; Steingart, R. M.; Norton, L.; Winer, E. P.; Hudis, C. A.
Abstract Title: Preliminary safety results of dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2 overexpressed/amplified breast cancer (BCA)
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 11s
Language: English
ACCESSION: WOS:000208457400169
PROVIDER: wos
DOI: 10.1200/jco.2008.26.15_suppl.518
Notes: Meeting Abstract: 518 -- Source: Wos
Altmetric Score
MSK Authors
  1. Andrew D Seidman
    243 Seidman
  2. Clifford Hudis
    837 Hudis
  3. Larry Norton
    556 Norton
  4. Chau Dang
    156 Dang
  5. Diana E Lake
    70 Lake
  6. Maura N Dickler
    237 Dickler
  7. Richard M Steingart
    113 Steingart
  8. Shanu Modi
    132 Modi